NL-OMON21194已完成不适用
Adherence and patients’ experiences with oral anticancer agents.
VU University Medical Center0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with cancer of 18 years and older who have filled at least one prescription for an oral anticancer agent in the past period of three months.
排除标准
- •1. Patients younger than 18 years;
- •2. Treatment in the (neo)adjuvant setting;
研究者
相似试验
已完成
不适用
Adherence and patients’ experiences with capecitabine.Colorectal cancer, gastric cancer and breast cancer.NL-OMON21382VU University Medical Center66
已完成
不适用
Adherence and patients’ experiences with erlotinib.CancerOral chemotherapyErlotinibAdherencePlasma concentrationLongkankerOrale chemotherapieErlotinibTherapietrouwPlasmaconcentratieNL-OMON26332VU medical centre, Amsterdam50
已完成
不适用
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?SchizoaffectiveSchizophreniaNCT00223522The University of Texas Health Science Center at San Antonio50
已完成
不适用
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrYAtrial FibrillationNCT03790917National Research Center for Preventive Medicine201
已完成
不适用
Survey on Medication Adherence to Direct Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation (NVAF)on-Valvular Atrial FibrillationJPRN-UMIN000034176Rakuwakai Otowa Hospital1,000